AMF Tjänstepension’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$68.5M Hold
542,262
0.41% 53
2026
Q1
$75.6M Buy
542,262
+17,302
+3% +$2.42M 0.5% 45
2025
Q4
$64.4M Hold
524,960
0.4% 54
2025
Q3
$58.3M Hold
524,960
0.37% 51
2025
Q2
$58.2M Buy
524,960
+154,530
+42% +$16.4M 0.39% 49
2025
Q1
$41.5M Sell
370,430
-30,389
-8% -$3.14M 0.31% 52
2024
Q4
$37.1M Hold
400,819
0.26% 48
2024
Q3
$33.6M Buy
400,819
+51,390
+15% +$3.92M 0.24% 56
2024
Q2
$24M Buy
+349,429
New +$23.3M 0.18% 63
2024
Q1
Sell
-355,709
Closed -$28.9M 79
2023
Q4
$28.9M Hold
355,709
0.25% 81
2023
Q3
$26.7M Sell
355,709
-231,774
-39% -$17.8M 0.26% 73
2023
Q2
$45.3M Sell
587,483
-30,698
-5% -$2.45M 0.42% 56
2023
Q1
$51.3M Buy
618,181
+62,817
+11% +$5.2M 0.53% 46
2022
Q4
$47.7M Hold
555,364
0.55% 50
2022
Q3
$34.3M Sell
555,364
-3,247
-0.6% -$205K 0.41% 56
2022
Q2
$34.6M Sell
558,611
-156,246
-22% -$9.67M 0.34% 58
2022
Q1
$42.6M Buy
714,857
+1,465
+0.2% +$93.6K 0.31% 68
2021
Q4
$51.9M Buy
713,392
+19,729
+3% +$1.36M 0.35% 64
2021
Q3
$48.5M Buy
693,663
+46,889
+7% +$3.29M 0.35% 68
2021
Q2
$44.6M Sell
646,774
-93,816
-13% -$6.26M 0.31% 73
2021
Q1
$47.9M Sell
740,590
-7,424
-1% -$479K 0.36% 65
2020
Q4
$43.7M Buy
748,014
+116,334
+18% +$7.02M 0.36% 66
2020
Q3
$39.9M Sell
631,680
-83,921
-12% -$5.82M 0.36% 68
2020
Q2
$55.1M Sell
715,601
-210,529
-23% -$16.1M 0.57% 47
2020
Q1
$69.2M Sell
926,130
-263,998
-22% -$18.2M 0.88% 29
2019
Q4
$77.3M Buy
1,190,128
+41,029
+4% +$2.67M 0.74% 41
2019
Q3
$72.8M Buy
1,149,099
+85,598
+8% +$5.6M 0.75% 38
2019
Q2
$71.8M Buy
1,063,501
+100,976
+10% +$6.64M 0.7% 43
2019
Q1
$62.6M Sell
962,525
-100,779
-9% -$6.7M 0.62% 45
2018
Q4
$66.5M Sell
1,063,304
-144,751
-12% -$10.1M 0.73% 35
2018
Q3
$93.3M Buy
1,208,055
+502
+0% +$37.9K 0.85% 32
2018
Q2
$85.5M Sell
1,207,553
-16,041
-1% -$1.13M 0.83% 35
2018
Q1
$92.2M Sell
1,223,594
-34,288
-3% -$2.73M 0.96% 28
2017
Q4
$90.1M Buy
1,257,882
+63,927
+5% +$4.85M 0.88% 34
2017
Q3
$96.7M Sell
1,193,955
-7,340
-0.6% -$561K 1.06% 21
2017
Q2
$81.6M Hold
1,201,295
0.93% 27
2017
Q1
$81.6M Sell
1,201,295
-69,141
-5% -$4.86M 0.93% 27
2016
Q4
$91M Buy
1,270,436
+91,680
+8% +$6.81M 1.06% 21
2016
Q3
$93.3M Sell
1,178,756
-457,950
-28% -$37.2M 1.17% 19
2016
Q2
$137M Sell
1,636,706
-125,401
-7% -$11.1M 1.76% 11
2016
Q1
$162M Buy
1,762,107
+88,629
+5% +$7.99M 2.12% 5
2015
Q4
$169M Buy
1,673,478
+62,600
+4% +$6.51M 2.38% 3
2015
Q3
$158M Sell
1,610,878
-900
-0.1% -$100K 2.4% 3
2015
Q2
$189M Sell
1,611,778
-186,759
-10% -$20.4M 2.62% 2
2015
Q1
$176M Sell
1,798,537
-355,152
-16% -$36.1M 2.22% 4
2014
Q4
$203M Buy
+2,153,689
New +$223M 2.56% 3

Other funds holding GILD

AMF Tjänstepension's GILD Position: Q2 2026 in Review

AMF Tjänstepension held its Gilead Sciences (GILD) position steady in Q2 2026 at 542,262 shares worth $68.5M. The position accounts for 0.41% of the portfolio, ranked #53.

AMF Tjänstepension first reported a position in GILD in Q4 2014 and has held it in 46 quarters since. The position peaked at $203M in Q4 2014. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • AMF Tjänstepension held 542,262 shares of Gilead Sciences worth $68.5M as of Q2 2026.
  • AMF Tjänstepension left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.41% of AMF Tjänstepension's portfolio in Q2 2026, its #53 holding.
  • AMF Tjänstepension first reported a position in Gilead Sciences in Q4 2014 and has held it in 46 quarters since.
  • AMF Tjänstepension's Gilead Sciences position peaked at $203M in Q4 2014.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on AMF Tjänstepension's 13F filing for Q2 2026, filed 6 Aug 2026.